North Carolina’s Novozymes has signed a deal with Lyngby-Taarbæk Municipality to acquire a 140,000 square meter site in Lyngby, Denmark. The site is located 13 kilometers north of Copenhagen and seven kilometers from its European headquarters in Bagsværd.
Novozymes’ goal is to build a new campus dedicated to research and business development.
“This is an investment in the future, where the new innovation campus will be a cornerstone for our global research. Novozymes is driven by innovation and this center will help strengthen our growth through developing ground-breaking biotechnology,” says Per Falholt, executive vice president for R&D at Novozymes.
More information is available here: http://www.novozymes.com/en/news/news-archive/Pages/Novozymes-to-establish-a-new-innovation-campus-in-Denmark.aspx
